The mechanistic studies demonstrated that the quinone derivative DMAKO-20 underwent tumor-specific CYP1B1-catalyzed oxidation to produce active naphthoquinone mono-oximes and nitric oxide, which exhibited synergistic anticancer effects. The gene discussed is CYP1B1; the disease is neoplasm.